Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bio-Gene Technology Ltd
BGTCurrent price
0.036 AUD
0 AUD (0.00%)
Last closed
0.036 AUD
Company
www.bio-gene.com.au
ISIN
AU000000BGT8
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
8 021 344 AUD
Yield for 12 month
-35.71 %
1Y
3Y
5Y
10Y
15Y
BGT
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University to support research and field operations relating to processing and distillation of oil from biomass; AgriFor Scientific, a chemistry product; cesar for assessing the insecticidal activity of molecules against a various insect species; CSIRO, a chemistry development process; Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University, a chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia. Address: 400 Collins Street, Melbourne, VIC, Australia, 3000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.57 AUDP/E ratio
–Dividend Yield
–Current Year
+18 245 AUD
Last Year
+592 630 AUD
Current Quarter
-434 AUD
Last Quarter
+18 677 AUD
Current Year
-300 208 AUD
Last Year
+280 645 AUD
Current Quarter
-129 425 AUD
Last Quarter
-170 783 AUD
Key Figures BGT
1 year
3 years
5 years
10 years
EBITDA
-2 447 731 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-44.61 %
PEG Ratio
–
Return On Equity TTM
-80.14 %
Wall Street Target Price
0.57 AUD
Revenue TTM
18 245 AUD
Book Value
0.014 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1.5 %
Dividend Yield
–
Gross Profit TTM
221 187 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BGT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
10.7329
Price Sales TTM
439.655
Enterprise Value EBITDA
-2.7057
Price Book MRQ
2.8857
Financials BGT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BGT
For 52 weeks
0.038 AUD
0.085 AUD
50 Day MA
0.05 AUD
Shares Short Prior Month
–
200 Day MA
0.054 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart